Resources by Therapeutic Area

Resources by Therapeutic Area

Findings from newly published research demonstrate promise of ultra-sensitive biomarker technology to identify and define high-risk populations through quantification of interferon (IFN) type I
Hadjadj J, Yatim N, Barnabei L, Corneau A, Boussier J, Smith N, Péré H, Charbit B, Bondet V, Chenevier-Gobeaux C, Breillat P, Carlier N, Gauzit R, Morbieu C, Pène F, Marin N, Roche N, Szwebel T-A, Merkling SH, Treluyer J-M, Veyer D, Mouthon L, Blanc C, Tharaux P-L, Rozenberg F, Fischer A, Duffy D
In this Possible Talk, Kevin Hrusovsky, President and CEO, Quanterix, and Founder of the non-profit, Powering Precision Health (PPH), explores the intersection of the need to return to "business as usual", the reliablilty of testing, and collaboration between science and politics against the back
Hoiland RL, Stukas S, Cooper J, Thiara S, Chen LYC, Biggs CM, Hay K, Lee AYY, Shojania K, Abdulla A, Wellington CL and Sekhon MS. Br J Haematol. 2020 Jun 25.  doi: 10.1111/bjh.16961

This website uses cookies. By continuing to use this website you are acknowledging and agree with our cookie policy.

AgreeLearn more